Literature DB >> 19931713

Disease and economic burden of rotavirus diarrhoea in India.

Jacqueline E Tate1, Shobha Chitambar, Douglas H Esposito, Rajiv Sarkar, Beryl Gladstone, Sasirekha Ramani, Mohan Venkata Raghava, Thuppal V Sowmyanarayanan, Swati Gandhe, Rashmi Arora, Umesh D Parashar, Gagandeep Kang.   

Abstract

We used published and unpublished studies and national statistics to estimate the number of deaths, hospitalizations, and outpatient visits due to rotavirus diarrhoea and the associated national economic burden of disease in India. Annually in India, rotavirus diarrhoea causes an estimated 122,000-153,000 deaths, 457,000-884,000 hospitalizations, and 2 million outpatient visits in children <5 years of age. India spends Rs 2.0-3.4 billion (US$ 41-72 million) annually in medical costs to treat rotavirus diarrhoea. The use of specific interventions against rotavirus, such as newly available vaccines, would help prevent much of this large disease and economic burden.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19931713     DOI: 10.1016/j.vaccine.2009.08.098

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  25 in total

Review 1.  Rotavirus vaccine RIX4414 (Rotarix™): a pharmacoeconomic review of its use in the prevention of rotavirus gastroenteritis in developing countries.

Authors:  Greg L Plosker
Journal:  Pharmacoeconomics       Date:  2011-11       Impact factor: 4.981

2.  Detection of rotavirus from hospitalized diarrheic children in uttar pradesh, India.

Authors:  S K Dash; Krishna Kumar; A Tewari; P Varshney; A Goel; A K Bhatia
Journal:  Indian J Microbiol       Date:  2012-06-22       Impact factor: 2.461

3.  Cost-effectiveness of a new rotavirus vaccination program in Pakistan: a decision tree model.

Authors:  Hiten D Patel; Eric T Roberts; Dagna O Constenla
Journal:  Vaccine       Date:  2013-10-29       Impact factor: 3.641

4.  Update on available vaccines in India: report of the APPA VU 2010: I.

Authors:  Sunil Karande
Journal:  Indian J Pediatr       Date:  2011-03-05       Impact factor: 1.967

5.  Immune mediators of rotavirus antigenemia clearance in mice.

Authors:  Glendie Marcelin; Amber D Miller; Sarah E Blutt; Margaret E Conner
Journal:  J Virol       Date:  2011-05-18       Impact factor: 5.103

6.  Should India launch a national immunisation programme against rotavirus? Yes.

Authors:  Johnie Rose; Umesh D Parashar
Journal:  BMJ       Date:  2012-11-30

7.  Estimated impact of rotavirus vaccine on hospitalizations and deaths from rotavirus diarrhea among children <5 in Asia.

Authors:  Eleanor Burnett; Jacqueline E Tate; Carl D Kirkwood; E Anthony S Nelson; Mathuram Santosham; A Duncan Steele; Umesh D Parashar
Journal:  Expert Rev Vaccines       Date:  2018-02-26       Impact factor: 5.217

8.  Cost-effectiveness analysis of introducing universal childhood rotavirus vaccination in Bangladesh.

Authors:  Abdur Razzaque Sarker; Marufa Sultana; Rashidul Alam Mahumud; Robert Van Der Meer; Alec Morton
Journal:  Hum Vaccin Immunother       Date:  2017-12-12       Impact factor: 3.452

9.  Immunogenicity and safety of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine (PRV) in Indian infants.

Authors:  M R Lokeshwar; Sheila Bhave; Ashok Gupta; V K Goyal; Anuj Walia
Journal:  Hum Vaccin Immunother       Date:  2013-01       Impact factor: 3.452

10.  Rotavirus mortality in India: estimates based on a nationally representative survey of diarrhoeal deaths.

Authors:  Shaun K Morris; Shally Awasthi; Ajay Khera; Diego G Bassani; Gagandeep Kang; Umesh D Parashar; Rajesh Kumar; Anita Shet; Roger I Glass; Prabhat Jha
Journal:  Bull World Health Organ       Date:  2012-07-16       Impact factor: 9.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.